BioAge Labs Overview
BioAge Labs Target Price
Where could BIOA trade next? Consensus target price: $31.
Get informed when a big investor buys or sells
+ FollowShare Price
$10.48
Average Target Price
$30.50
191% upside
191% upside4 analysts in the last 4 months
High: $40 | Low: $21
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-07-31 | Roth CapitalAdam Walsh | $25 | 138.5% upside |  |
| 2026-07-31 | Jefferies | $21 | 100.4% upside | |
| 2026-05-27 | Roth CapitalAdam Walsh | $36 | 243.5% upside | |
| 2026-05-13 | BTIG | $40 | 281.7% upside | |
| 2026-03-27 | Needham | $50 | 377.1% upside | |
| 2026-02-18 | JefferiesRoger Song | $62 | 491.6% upside | |
| 2026-02-04 | Morgan Stanley | $23 | 119.5% upside | |
| 2025-12-05 | Morgan Stanley | $12 | 14.5% upside | |
| 2025-03-07 | Morgan Stanley | $5 |  52.3% downside | |
| 2024-12-09 | JefferiesRoger Song | $7 | 33.2% downside | |
| 2024-10-21 | CitigroupSamantha Semenkow | $45 | 329.4% upside | |
| 2024-10-21 | JefferiesRoger Song | $42 | 300.8% upside | |
| 2024-10-21 | Morgan StanleyJeffrey Hung | $40 | 281.7% upside | |